Elanco

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Elanco and other ETFs, options, and stocks.

About ELAN

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. 

CEO
Jeffrey N. Simmons
CEOJeffrey N. Simmons
Employees
9,450
Employees9,450
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1954
Founded1954
Employees
9,450
Employees9,450

ELAN Key Statistics

Market cap
10.48B
Market cap10.48B
Price-Earnings ratio
289.30
Price-Earnings ratio289.30
Dividend yield
Dividend yield
Average volume
7.19M
Average volume7.19M
High today
$21.99
High today$21.99
Low today
$21.07
Low today$21.07
Open price
$21.58
Open price$21.58
Volume
4.61M
Volume4.61M
52 Week high
$23.09
52 Week high$23.09
52 Week low
$8.02
52 Week low$8.02

Stock Snapshot

As of today, Elanco(ELAN) shares are valued at $21.09. The company's market cap stands at 10.48B, with a P/E ratio of 289.30.

As of 2025-11-16, Elanco(ELAN) stock has fluctuated between $21.07 and $21.99. The current price stands at $21.09, placing the stock +0.1% above today's low and -4.1% off the high.

The Elanco(ELAN)'s current trading volume is 4.61M, compared to an average daily volume of 7.19M.

During the past year, Elanco(ELAN) stock moved between $8.02 at its lowest and $23.09 at its peak.

During the past year, Elanco(ELAN) stock moved between $8.02 at its lowest and $23.09 at its peak.

ELAN News

Simply Wall St 5d
How Investors May Respond To Elanco Animal Health Lowering 2025 Earnings Guidance Despite Higher Sales

Elanco Animal Health recently reported its third quarter 2025 results, showing higher sales of US$1.14 billion compared to US$1.03 billion a year ago, but poste...

How Investors May Respond To Elanco Animal Health Lowering 2025 Earnings Guidance Despite Higher Sales
TipRanks 6d
Elanco price target raised to $24 from $18 at Piper Sandler

Piper Sandler analyst David Westenberg raised the firm’s price target on Elanco (ELAN) to $24 from $18 following quarterly results. The firm keeps a Neutral rat...

Analyst ratings

69%

of 16 ratings
Buy
68.8%
Hold
25%
Sell
6.3%

People also own

Based on the portfolios of people who own ELAN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.